Brief: Vaxxinity Initiates Rolling Submission For Ub-612 Covid-19 Vaccine With MHRA(UK)
12/09/2022 13:42
Sept 12 (Reuters) - Vaxxinity Inc VAXX.O :
* VAXXINITY INC - INITIATES ROLLING SUBMISSION FOR UB-612
COVID-19
VACCINE WITH MHRA (UK)
* VAXXINITY INC - REITERATES ITS PLAN TO HAVE A TOPLINE
READOUT OF
PHASE 3 TRIAL IN Q4 OF 2022
Source text for Eikon: ID:nGNX6jWSG9
Further company coverage: VAXX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Vaxxinity
See all newsU.S. STOCKS ON THE MOVE-EV stocks, Salesforce, Verizon
Brief: Vaxxinity Announces Intention To Voluntarily Delist And Deregister Its Class A Common Stock
Brief: Vaxxinity Announces Intention To Voluntarily Delist And Deregister Its Class A Common Stock
Brief: Vaxxinity Q4 Net Income USD -11.392 Million
Vaxxinity Inc expected to post a loss of 10 cents a share - Earnings Preview